Left-sided primary tumors are associated with favorable prognosis in patients with KRAS codon 12/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: an analysis of the AIO KRK-0104 trial
作者： S. Boeck , C. Schulz , C. Giessen , S. Stintzing , D. P. Modest
DOI: 10.1007/S00432-014-1678-3
关键词:
摘要: Purpose AIO KRK-0104 investigated first-line therapy of metastatic colorectal cancer (mCRC) with cetuximab, capecitabine and irinotecan versus oxaliplatin. This analysis the impact primary tumor location on outcome patients.
springer.com
core.ac.uk
paperity.org
researchgate.net 参考文章(21)
N. Moosmann, L. Fischer von Weikersthal, U. Vehling-Kaiser, M. Stauch, H. F. Dietzfelbinger, D. V. Oruzio, S. Klein, S. Stintzing, V. Heinemann, Final analysis of the randomized trial of the German AIO CRC study group: Cetuximab plus XELIRI versus cetuximab plus XELOX as first-line treatment for patients with metastatic colorectal cancer (mCRC). Journal of Clinical Oncology. ,vol. 28, pp. 3540- 3540 ,(2010) , 10.1200/JCO.2010.28.15_SUPPL.3540
Wendy De Roock, Derek J. Jonker, Federica Di Nicolantonio, Andrea Sartore-Bianchi, Dongsheng Tu, Salvatore Siena, Simona Lamba, Sabrina Arena, Milo Frattini, Hubert Piessevaux, Eric Van Cutsem, Chris J. O’Callaghan, Shirin Khambata-Ford, John R. Zalcberg, John Simes, Christos S. Karapetis, Alberto Bardelli, Sabine Tejpar, Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab JAMA. ,vol. 304, pp. 1812- 1820 ,(2010) , 10.1001/JAMA.2010.1535
Vlad Popovici, Eva Budinska, Fred T Bosman, Sabine Tejpar, Arnaud D Roth, Mauro Delorenzi, Context-dependent interpretation of the prognostic value of BRAF and KRAS mutations in colorectal cancer BMC Cancer. ,vol. 13, pp. 439- 439 ,(2013) , 10.1186/1471-2407-13-439
Jean-Yves Douillard, Kelly S Oliner, Salvatore Siena, Josep Tabernero, Ronald Burkes, Mario Barugel, Yves Humblet, Gyorgy Bodoky, David Cunningham, Jacek Jassem, Fernando Rivera, Ilona Kocákova, Paul Ruff, Maria Błasińska-Morawiec, Martin Šmakal, Jean Luc Canon, Mark Rother, Richard Williams, Alan Rong, Jeffrey Wiezorek, Roger Sidhu, Scott D Patterson, None, Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer The New England Journal of Medicine. ,vol. 369, pp. 1023- 1034 ,(2013) , 10.1056/NEJMOA1305275
Andreas Jung, Nicolas Moosmann, Wolfgang Hiddemann, Thomas Kirchner, Sebastian Stintzing, Volker Heinemann, The Treatment of Colorectal Carcinoma With Monoclonal Antibodies - The Importance of KRAS Mutation Analysis and EGFR Status Deutsches Aerzteblatt Online. ,vol. 106, pp. 202- 206 ,(2009) , 10.3238/ARZTEBL.2009.0202
Jean-Yves Douillard, Salvatore Siena, James Cassidy, Josep Tabernero, Ronald Burkes, Mario Barugel, Yves Humblet, György Bodoky, David Cunningham, Jacek Jassem, Fernando Rivera, Ilona Kocákova, Paul Ruff, Maria Błasińska-Morawiec, Martin Šmakal, Jean-Luc Canon, Mark Rother, Kelly S Oliner, Michael Wolf, Jennifer Gansert, None, Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study Journal of Clinical Oncology. ,vol. 28, pp. 4697- 4705 ,(2010) , 10.1200/JCO.2009.27.4860
Mai Yamauchi, Teppei Morikawa, Aya Kuchiba, Yu Imamura, Zhi Rong Qian, Reiko Nishihara, Xiaoyun Liao, Levi Waldron, Yujin Hoshida, Curtis Huttenhower, Andrew T Chan, Edward Giovannucci, Charles Fuchs, Shuji Ogino, Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum Gut. ,vol. 61, pp. 847- 854 ,(2012) , 10.1136/GUTJNL-2011-300865
Marc Peeters, Jean-Yves Douillard, Eric Van Cutsem, Salvatore Siena, Kathy Zhang, Richard Williams, Jeffrey Wiezorek, Mutant KRAS Codon 12 and 13 Alleles in Patients With Metastatic Colorectal Cancer: Assessment As Prognostic and Predictive Biomarkers of Response to Panitumumab Journal of Clinical Oncology. ,vol. 31, pp. 759- 765 ,(2013) , 10.1200/JCO.2012.45.1492
Rafael G. Amado, Michael Wolf, Marc Peeters, Eric Van Cutsem, Salvatore Siena, Daniel J. Freeman, Todd Juan, Robert Sikorski, Sid Suggs, Robert Radinsky, Scott D. Patterson, David D. Chang, Wild-TypeKRASIs Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer Journal of Clinical Oncology. ,vol. 26, pp. 1626- 1634 ,(2008) , 10.1200/JCO.2007.14.7116
Mai Yamauchi, Paul Lochhead, Teppei Morikawa, Curtis Huttenhower, Andrew T Chan, Edward Giovannucci, Charles Fuchs, Shuji Ogino, Colorectal cancer: a tale of two sides or a continuum? Gut. ,vol. 61, pp. 794- 797 ,(2012) , 10.1136/GUTJNL-2012-302014